tiprankstipranks

Scott Capps Insider Profile

4 Followers
Scott Capps, VP, Clinical Research at Artivion, holds 153.20K shares in Artivion (Ticker: AORT).
tipranks
Scott Capps

Scott Capps
Artivion (AORT)
VP, Clinical Research

Not Ranked
Scott Capps has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
100.00%
A breakdown of Scott Capps's holdings

Insider Roles

Artivion
(AORT)
VP, Clinical Research
Roles that Scott Capps holds in companies

Most Profitable Insider Trade

Stock:
Artivion
(AORT)
Rating:Informative Sell
Date:Jun 03, 2019 - Jun 03, 2020
Return:+18.50%
The most profitable trade made by Scott Capps

Scott Capps's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Artivion
Mar 15, 2021
VP, Clinical Research
Uninformative Sell
34.89K
$3.11M
Success Rate for
AORT
1 out of 1 profitable transactions on
AORT
100%
Average Return for
AORT
Average return per transaction on
AORT
+18.50%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Feb 22, 2012
Uninformative Buy
$0.00
-
$0.00
Feb 24, 2011
Uninformative Buy
$0.00
-
$0.00
Feb 17, 2010
Uninformative Buy
$0.00
-
$0.00
Feb 18, 2009
Uninformative Buy
$0.00
-
$0.00
Feb 19, 2013
Uninformative Buy
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see Scott Capps's performance on stock

Scott Capps insider profile FAQ

What is the percentage of profitable transactions made by Scott Capps?
The percentage of profitable transactions made by Scott Capps is ―.
    What is the average return per transaction made by Scott Capps?
    The average return per transaction made by Scott Capps is ―.
      What stocks does Scott Capps hold?
      Scott Capps holds: AORT stocks.
        What was Scott Capps’s latest transaction?
        Scott Capps latest transaction was an Uninformative Sell of $34.89K.
          What was Scott Capps's most profitable transaction?
          Scott Capps’s most profitable transaction was an Informative Sell of AORT stock on June 3, 2019. The return on the trade was 18.50%.
            What is Scott Capps's role in Artivion?
            Scott Capps's role in Artivion is VP, Clinical Research.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.